InDex Pharmaceuticals is attending the UEGW 2023 congress
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) will attend the United European Gastroenterology Week (UEGW), one of the world's leading...
Source: prnewswire.com
Page 2 - Johan Gil News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Johan Gil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Johan Gil Today - Breaking & Trending Today
'Positive results from PK study with cobitolimod' selected as one of the best abstracts for poster presentation at UEGW:
STOCKHOLM, Aug. 22, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the...
Source: europapress.es
InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new formulation patent for the drug candidate cobitolimod has been granted by...
Source: prnewswire.com
InDex Pharmaceuticals announces license agreement with Viatris Japan to develop and commercialize cobitolimod in Japan
STOCKHOLM, May 31, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex") today announced that a license agreement has been signed with Viatris Pharmaceutical Japan Inc. ("Viatris
Source: finanznachrichten.de
InDex Pharmaceuticals' investor call at 15:00 CET on June 1
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) will hold an investor call in light of today's press release announcing the company's license agreement....
Source: prnewswire.com